Statistics
Publications
3
Citations
436
H-Index
3
Active since
1995
Affiliations
University of Michigan(Current)
Mark W. Ealovega is an author at University of Michigan specializing in apoptosis in cancer, bcl-2 family proteins, and bcl-xl function.
Publications per year
1995–2004
3
3
Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis.
Venil N. Sumantran, Mark W. Ealovega, Gabriel Núñez et al. · PubMed · 1995 · 197 citations
Medicine, Oncology, Pharmacology +17
Opportunistic Screening for Diabetes in Routine Clinical Practice
Mark W. Ealovega, Bahman P. Tabaei, Michael Brändle et al. · Diabetes Care · 2004 · 159 citations · Full text
bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice.
Mark W. Ealovega, Patrick K. McGinnis, Venil N. Sumantran et al. · PubMed · 1996 · 80 citations
1–3 of 3